Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Clinical trial NCT07435038 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07435038
Sponsor: Betta Pharmaceuticals Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)Advanced Solid Tumors

Start date: 2026-02-12
Primary completion: 2028-12-28
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.